Skip to main content
Erschienen in:

01.02.2020 | Genetics

The second mutation of SYCE1 gene associated with autosomal recessive nonobstructive azoospermia

verfasst von: Mahdieh Pashaei, Mohammad Masoud Rahimi Bidgoli, Davood Zare-Abdollahi, Hossein Najmabadi, Ramona Haji-Seyed-Javadi, Farzad Fatehi, Afagh Alavi

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

It is estimated that 40–50% of infertility among human couples is due to male infertility. Azoospermia is estimated to occur in 1% of all men and to be the cause of 10–20% of male infertility. Genetic defects, including single gene effects, maybe cause of azoospermia in 20–30% of affected males. Here, we aim to identify the genetic cause of azoospermia in a man who is also affected by hereditary spastic paraplegia.

Methods

The proband was subjected to whole-exome sequencing, followed by a comprehensive in silico analysis to identify the azoospermia causative gene.

Results

A novel splice site mutation c.375-2A > G in SYCE1 that is thought to be the cause of azoospermia was identified. This variant co-segregated with azoospermia status in the family that has three additional affected males.

Conclusion

SYCE1 gene encodes synaptonemal complex (SC) central element 1 protein which contributes to the formation of the synaptonemal complex during meiosis. Syce1 null male and female mice have been shown to be infertile. There have only been two reports on the effects of SYCE1 mutations in humans; it was shown as the cause of primary ovarian failure (POI) in one and as the cause of nonobstructive azoospermia (NOA) in another. We suggest that the mutation 375-2A > G, which affects the acceptor splice site within intron 6 of SYCE1, is the likely cause of azoospermia and subsequent infertility in the family studied. The finding constitutes the third report of SYCE1mutations that affect infertility in humans and further supports its contribution to this condition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zegers-Hochschild F, Adamson G, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. Technology ICfMAR, organization WH. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Fertil Steril. 2009;92(5):1520–4.CrossRef Zegers-Hochschild F, Adamson G, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. Technology ICfMAR, organization WH. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Fertil Steril. 2009;92(5):1520–4.CrossRef
2.
Zurück zum Zitat Rapino C, Battista N, Bari M, Maccarrone M. Endocannabinoids as biomarkers of human reproduction. Hum Reprod Update. 2014;20(4):501–16.CrossRef Rapino C, Battista N, Bari M, Maccarrone M. Endocannabinoids as biomarkers of human reproduction. Hum Reprod Update. 2014;20(4):501–16.CrossRef
3.
Zurück zum Zitat Di Spiezio SA, Di Carlo C, Minozzi S, Spinelli M, Pistotti V, Alviggi C, et al. Efficacy of hysteroscopy in improving reproductive outcomes of infertile couples: a systematic review and meta-analysis. Hum Reprod Update. 2016;22(4):479–96.CrossRef Di Spiezio SA, Di Carlo C, Minozzi S, Spinelli M, Pistotti V, Alviggi C, et al. Efficacy of hysteroscopy in improving reproductive outcomes of infertile couples: a systematic review and meta-analysis. Hum Reprod Update. 2016;22(4):479–96.CrossRef
4.
Zurück zum Zitat Miyamoto T, Minase G, Shin T, Ueda H, Okada H, Sengoku K. Human male infertility and its genetic causes. Reprod Med Biol. 2017;16(2):81–8.CrossRef Miyamoto T, Minase G, Shin T, Ueda H, Okada H, Sengoku K. Human male infertility and its genetic causes. Reprod Med Biol. 2017;16(2):81–8.CrossRef
5.
Zurück zum Zitat Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. J Urol. 1989;142(1):62–5.CrossRef Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. J Urol. 1989;142(1):62–5.CrossRef
6.
Zurück zum Zitat Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics. 2013;68:27–34.CrossRef Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics. 2013;68:27–34.CrossRef
7.
Zurück zum Zitat Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO manual for the standardized investigation, Diagnosis and Management of the Infertile Male. 1rd ed. Cambridge: Cambridge University Press; 2000. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO manual for the standardized investigation, Diagnosis and Management of the Infertile Male. 1rd ed. Cambridge: Cambridge University Press; 2000.
8.
Zurück zum Zitat Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S, et al. Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J Assist Reprod Genet. 2015;32(6):887–91.CrossRef Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S, et al. Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J Assist Reprod Genet. 2015;32(6):887–91.CrossRef
9.
Zurück zum Zitat Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369–384.CrossRef Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369–384.CrossRef
10.
Zurück zum Zitat Oud MS, Volozonoka L, Smits RM, Vissers LE, Ramos L, Veltman JA. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019;34(5):932–41.CrossRef Oud MS, Volozonoka L, Smits RM, Vissers LE, Ramos L, Veltman JA. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019;34(5):932–41.CrossRef
11.
Zurück zum Zitat Hamada AJ, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics. 2013;68:39–60.CrossRef Hamada AJ, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics. 2013;68:39–60.CrossRef
12.
Zurück zum Zitat Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A. Role of genetics in azoospermia. Urology. 2011;77(3):598–601.CrossRef Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A. Role of genetics in azoospermia. Urology. 2011;77(3):598–601.CrossRef
13.
Zurück zum Zitat Vog P, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933–43.CrossRef Vog P, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933–43.CrossRef
14.
Zurück zum Zitat Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl. 2012;14(1):32–9.CrossRef Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl. 2012;14(1):32–9.CrossRef
15.
Zurück zum Zitat Eggers S, DeBoer KD, van den Bergen J, Gordon L, White SJ, Jamsai D, et al. Copy number variation associated with meiotic arrest in idiopathic male infertility. Fertil Steril. 2015;103(1):214–9.CrossRef Eggers S, DeBoer KD, van den Bergen J, Gordon L, White SJ, Jamsai D, et al. Copy number variation associated with meiotic arrest in idiopathic male infertility. Fertil Steril. 2015;103(1):214–9.CrossRef
16.
Zurück zum Zitat Schilit SL, Menon S, Friedrich C, Kammin T, Wilch E, Hanscom C, et al. SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility. bioRxiv. 2019;pii: S0002–9297(19)30434–3. Schilit SL, Menon S, Friedrich C, Kammin T, Wilch E, Hanscom C, et al. SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility. bioRxiv. 2019;pii: S0002–9297(19)30434–3.
17.
Zurück zum Zitat Miyamoto T, Hasuike S, Yogev L, Maduro MR, Ishikawa M, Westphal H, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet. 2003;362(9397):1714–9.CrossRef Miyamoto T, Hasuike S, Yogev L, Maduro MR, Ishikawa M, Westphal H, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet. 2003;362(9397):1714–9.CrossRef
18.
Zurück zum Zitat He W-B, Tu C-F, Liu Q, Meng L-L, Yuan S-M, Luo A-X, et al. DMC1 mutation that causes human non-obstructive azoospermia and premature ovarian insufficiency identified by whole-exome sequencing. J Med Genet. 2018;55(3):198–204.PubMed He W-B, Tu C-F, Liu Q, Meng L-L, Yuan S-M, Luo A-X, et al. DMC1 mutation that causes human non-obstructive azoospermia and premature ovarian insufficiency identified by whole-exome sequencing. J Med Genet. 2018;55(3):198–204.PubMed
19.
Zurück zum Zitat Zhang YX, Li HY, He WB, Tu C, Du J, Li W, et al. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans. Clin Genet. 2019;95(3):442–3.CrossRef Zhang YX, Li HY, He WB, Tu C, Du J, Li W, et al. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans. Clin Genet. 2019;95(3):442–3.CrossRef
20.
Zurück zum Zitat de Vries LBD, Smirin-Yosef P, Lagovsky I, Tzur S, Basel-Vanagaite L. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J Clin Endocrinol Metab. 2014;99(10):E2129–E32.CrossRef de Vries LBD, Smirin-Yosef P, Lagovsky I, Tzur S, Basel-Vanagaite L. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J Clin Endocrinol Metab. 2014;99(10):E2129–E32.CrossRef
21.
Zurück zum Zitat Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in genie. J Comput Biol. 1997;4(3):311–23.CrossRef Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in genie. J Comput Biol. 1997;4(3):311–23.CrossRef
22.
Zurück zum Zitat Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res, 2009. 37(9):e67.CrossRef Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res, 2009. 37(9):e67.CrossRef
23.
Zurück zum Zitat Geisinger A, Benavente R. Mutations in genes coding for synaptonemal complex proteins and their impact on human fertility. Cytogenet Genome Res. 2016;150(2):77–85.CrossRef Geisinger A, Benavente R. Mutations in genes coding for synaptonemal complex proteins and their impact on human fertility. Cytogenet Genome Res. 2016;150(2):77–85.CrossRef
24.
Zurück zum Zitat Dunne OM, Davies OR. Molecular structure of human synaptonemal complex protein SYCE1. Chromosoma. 2019:128(3):223–236.CrossRef Dunne OM, Davies OR. Molecular structure of human synaptonemal complex protein SYCE1. Chromosoma. 2019:128(3):223–236.CrossRef
25.
Zurück zum Zitat Liu J-G, Yuan L, Brundell E, Björkroth B, Daneholt B, Höög C. Localization of the N-terminus of SCP1 to the central element of the synaptonemal complex and evidence for direct interactions between the N-termini of SCP1 molecules organized head-to-head. Exp Cell Res. 1996;226(1):11–9.CrossRef Liu J-G, Yuan L, Brundell E, Björkroth B, Daneholt B, Höög C. Localization of the N-terminus of SCP1 to the central element of the synaptonemal complex and evidence for direct interactions between the N-termini of SCP1 molecules organized head-to-head. Exp Cell Res. 1996;226(1):11–9.CrossRef
26.
Zurück zum Zitat Bolcun-Filas E, Costa Y, Speed R, Taggart M, Benavente R, De Rooij DG, et al. SYCE2 is required for synaptonemal complex assembly, double strand break repair, and homologous recombination. J Cell Biol. 2007;176(6):741–7.CrossRef Bolcun-Filas E, Costa Y, Speed R, Taggart M, Benavente R, De Rooij DG, et al. SYCE2 is required for synaptonemal complex assembly, double strand break repair, and homologous recombination. J Cell Biol. 2007;176(6):741–7.CrossRef
27.
Zurück zum Zitat Hamer G, Gell K, Kouznetsova A, Novak I, Benavente R, Höög C. Characterization of a novel meiosis-specific protein within the central element of the synaptonemal complex. J Cell Sci. 2006;119(19):4025–32.CrossRef Hamer G, Gell K, Kouznetsova A, Novak I, Benavente R, Höög C. Characterization of a novel meiosis-specific protein within the central element of the synaptonemal complex. J Cell Sci. 2006;119(19):4025–32.CrossRef
28.
Zurück zum Zitat Yang F, De La Fuente R, Leu NA, Baumann C, McLaughlin KJ, Wang PJ. Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis. J Cell Biol. 2006;173(4):497–507.CrossRef Yang F, De La Fuente R, Leu NA, Baumann C, McLaughlin KJ, Wang PJ. Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis. J Cell Biol. 2006;173(4):497–507.CrossRef
29.
Zurück zum Zitat Yuan L, Liu J-G, Zhao J, Brundell E, Daneholt B, Höög C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol Cell. 2000;5(1):73–83.CrossRef Yuan L, Liu J-G, Zhao J, Brundell E, Daneholt B, Höög C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol Cell. 2000;5(1):73–83.CrossRef
30.
Zurück zum Zitat Costa Y, Speed R, Öllinger R, Alsheimer M, Semple CA, Gautier P, et al. Two novel proteins recruited by synaptonemal complex protein 1 (SYCP1) are at the centre of meiosis. J Cell Sci. 2005;118(12):2755–62.CrossRef Costa Y, Speed R, Öllinger R, Alsheimer M, Semple CA, Gautier P, et al. Two novel proteins recruited by synaptonemal complex protein 1 (SYCP1) are at the centre of meiosis. J Cell Sci. 2005;118(12):2755–62.CrossRef
31.
Zurück zum Zitat Davies OR, Maman JD, Pellegrini L. Structural analysis of the human SYCE2–TEX12 complex provides molecular insights into synaptonemal complex assembly. Open Biol. 2012;2(7):120099.CrossRef Davies OR, Maman JD, Pellegrini L. Structural analysis of the human SYCE2–TEX12 complex provides molecular insights into synaptonemal complex assembly. Open Biol. 2012;2(7):120099.CrossRef
32.
Zurück zum Zitat Schramm S, Fraune J, Naumann R, Hernandez-Hernandez A, Höög C, Cooke HJ, et al. A novel mouse synaptonemal complex protein is essential for loading of central element proteins, recombination, and fertility. PLoS Genet. 2011;7(5):e1002088.CrossRef Schramm S, Fraune J, Naumann R, Hernandez-Hernandez A, Höög C, Cooke HJ, et al. A novel mouse synaptonemal complex protein is essential for loading of central element proteins, recombination, and fertility. PLoS Genet. 2011;7(5):e1002088.CrossRef
33.
Zurück zum Zitat Bolcun-Filas E, Speed R, Taggart M, Grey C, de Massy B, Benavente R, et al. Mutation of the mouse Syce1 gene disrupts synapsis and suggests a link between synaptonemal complex structural components and DNA repair. PLoS Genet. 2009;5(2):e1000393.CrossRef Bolcun-Filas E, Speed R, Taggart M, Grey C, de Massy B, Benavente R, et al. Mutation of the mouse Syce1 gene disrupts synapsis and suggests a link between synaptonemal complex structural components and DNA repair. PLoS Genet. 2009;5(2):e1000393.CrossRef
34.
Zurück zum Zitat de Vries FA, de Boer E, van den Bosch M, Baarends WM, Ooms M, Yuan L, et al. Mouse Sycp1 functions in synaptonemal complex assembly, meiotic recombination, and XY body formation. Genes Dev. 2005;19(11):1376–89.CrossRef de Vries FA, de Boer E, van den Bosch M, Baarends WM, Ooms M, Yuan L, et al. Mouse Sycp1 functions in synaptonemal complex assembly, meiotic recombination, and XY body formation. Genes Dev. 2005;19(11):1376–89.CrossRef
35.
Zurück zum Zitat Hamer G, Wang H, Bolcun-Filas E, Cooke HJ, Benavente R, Höög C. Progression of meiotic recombination requires structural maturation of the central element of the synaptonemal complex. J Cell Sci. 2008;121(15):2445–51.CrossRef Hamer G, Wang H, Bolcun-Filas E, Cooke HJ, Benavente R, Höög C. Progression of meiotic recombination requires structural maturation of the central element of the synaptonemal complex. J Cell Sci. 2008;121(15):2445–51.CrossRef
36.
Zurück zum Zitat Nishiyama S, Kishi T, Kato T, Suzuki M, Bolor H, Nishizawa H, et al. A rare synaptonemal complex protein 3 gene variant in unexplained female infertility. Mol Hum Reprod. 2010;17(4):266–71.CrossRef Nishiyama S, Kishi T, Kato T, Suzuki M, Bolor H, Nishizawa H, et al. A rare synaptonemal complex protein 3 gene variant in unexplained female infertility. Mol Hum Reprod. 2010;17(4):266–71.CrossRef
37.
Zurück zum Zitat Lu J, Gu Y, Feng J, Zhou W, Yang X, Shen Y. Structural insight into the central element assembly of the synaptonemal complex. Sci Rep. 2014;4:7059.CrossRef Lu J, Gu Y, Feng J, Zhou W, Yang X, Shen Y. Structural insight into the central element assembly of the synaptonemal complex. Sci Rep. 2014;4:7059.CrossRef
Metadaten
Titel
The second mutation of SYCE1 gene associated with autosomal recessive nonobstructive azoospermia
verfasst von
Mahdieh Pashaei
Mohammad Masoud Rahimi Bidgoli
Davood Zare-Abdollahi
Hossein Najmabadi
Ramona Haji-Seyed-Javadi
Farzad Fatehi
Afagh Alavi
Publikationsdatum
01.02.2020
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 2/2020
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-019-01660-1

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Junge Brustkrebspatientinnen zum Durchhalten motivieren

Patientinnen, die in jungen Jahren an Hormonrezeptor-positivem Brustkrebs erkranken, neigen dazu, die adjuvante endokrine Therapie auszusetzen oder abzubrechen. Die schlechte Therapiepersistenz scheint die Rückkehr des Tumors zu begünstigen.

Krebsscreeningprogramme erreichen Menschen mit kognitiver Beeinträchtigung schlechter

Daten aus den Niederlanden zeigen, dass Krebsfrüherkennungsmaßnahmen für Menschen mit Störungen der Intelligenzentwicklung häufig nicht zugänglich sind. Wie kann diese Lücke geschlossen werden?

Folgetumoren nach TNBC sind oft Hormonrezeptor-positiv

Frauen mit triple-negativem Brustkrebs (TNBC) erhalten nach der Primärbehandlung üblicherweise keine chemopräventive endokrine Therapie. Folgt man den Ergebnissen einer Studie, könnte das vielleicht ein Fehler sein.

Zervixkarzinom-Screening: mit 65 Jahren Schluss?

Möglicherweise profitieren nicht alle Frauen über 65 Jahre von einer Fortsetzung des Screenings auf Gebärmutterhalskrebs. Aktuelle Modellrechnungen anhand von US-Daten legen nahe, wie eine Exit-Strategie aussehen könnte.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.